Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2023 | Implementing AI in hematology and the challenges this will overcome

Torsten Haferlach • 9 Dec 2023
ASH 2023
General

Torsten Haferlach, MD, PhD, MLL Munich Leukemia Laboratory, Munich, Germany, discusses the challenges that the advent of artificial intelligence (AI) will overcome in hematology and comments on the necessary process which will allow for the implementation of these tools. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

MLL Munich Leukemia Laboratory: Current Employment; Other: Equity Ownership.

More from Torsten Haferlach

3:33
The value of WGS and whole transcriptome sequencing in the diagnosis of hematological malignancies
Torsten Haferlach • 9 Dec 2023
2:57
Why do we need AI in the hematology clinic?
Torsten Haferlach • 9 Dec 2023
1:53
Role of NGS in acute leukemias
Torsten Haferlach • 17 Sep 2020
2:00
MRD detection with NGS for AML: a new era of diagnostics
Torsten Haferlach • 19 Jun 2019

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals